Raymond James Financial Inc. Purchases New Stake in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
Raymond James Financial Inc. purchased a new position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 108,989 shares of the company’s stock, valued at approximately $583,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CRVS. […]
Raymond James Financial Inc. purchased a new position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 108,989 shares of the company’s stock, valued at approximately $583,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CRVS. […]
